{"name": "Insero Health",
 "permalink": "insero-health",
 "crunchbase_url": "http://www.crunchbase.com/company/insero-health",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "dkolb@inserohealth.com",
 "phone_number": "786 300-4600 ",
 "description": "",
 "created_at": "Fri Feb 03 03:17:50 UTC 2012",
 "updated_at": "Fri Feb 03 03:17:49 UTC 2012",
 "overview": "\u003Cp\u003EInsero Health, Inc. is a privately held healthcare company involved in the discovery, development and commercialization of pharmaceuticals derived from natural products for the treatment of epilepsy and related conditions.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "David",
      "last_name": "Kolb",
      "permalink": "david-kolb",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.bizjournals.com/tampabay/prnewswire/press_releases/Florida/2012/02/02/NY46508",
    "source_description": "Insero Health Closes Initial Round of Financing and Signs Exclusive Licenses With Harvard and Yale",
    "raised_amount": 1100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 2,
    "funded_day": 2,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}